Publication | Closed Access

Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization

Percutaneous Coronary InterventionCardiovascular DiseaseMedicineCardiovascular PharmacologyCoronary RevascularizationPharmacotherapyAcute Myocardial InfarctionCalmodulin AntagonistPharmacologyCardiologyMyocardial FunctionCoronary Artery DiseaseAnesthesiologyMyocardial Infarction